Introduction:

Risk scales are helpful in the primary prevention of cardiovascular (CV) diseases to detect high-risk subjects. In Mexico, scales developed in populations very different from ours are used. Recently, the use of the Globorisk tool in Mexico has been proposed. We have shown that the ACC/AHA scale underestimates the risk measured with the TG/HDL-c index and the so-called Lindavista score. We now compare these last to the risk calculated with the Globorisk tool, whose original estimates were adjusted to national data.

Material and methods:

The sum of the abnormalities in the data of 2,602 healthy subjects (age, gender, body mass, waist, lipid profile, and blood glucose) is the Lindavista score. This and the quartile values of the TG/HDL-c index were compared with the Globorisk risk estimate for Mexico.

Results:

Lindavista risk and TG/HDL-c ratio values have a very high linear correlation, but Globorisk underestimates the risk.

Conclusion:

Any scale that does not consider traits and factors that are highly prevalent in our population (abdominal obesity and lipid triad) can correctly express the risk. While waiting to develop our scale that encloses the anthropometric and cardiometabolic traits of the Mexican population, the TG/HDL-c index is proposed as a valuable, economical, and practical tool for estimating the risk of our population.

        · abstract in Spanish     · text in English     · English ( pdf )